McFarlane Neil F. — SEC insider filings
SEC reporting owner CIK 1681098. 15 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2021-03-03 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 236,942 shares, $2,141,857 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 91,000 shares @ $9.38 ($853,425) in ZEVRA THERAPEUTICS, INC., filed 2026-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. (ZVRA) | President and CEO, Director | 9 | — | 6 legs · 236,942 sh · $2,141,857 | 17 |
| Adamas Pharmaceuticals Inc (ADMS) | Chief Executive Officer, Director | 2 | — | — | 5 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | 4 | — | — | 4 |
Insider filings — McFarlane Neil F.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 50,000 · Sale (S): 20,000 @ $11.25 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 37,500 · Sale (S): 14,625 @ $8.56 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 233,334 · Sale (S): 91,000 @ $9.38 · Grant/award (A): 125,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0 · Option exercise (M): 233,334 (derivative) @ $0 | EDGAR |
| 2025-10-10 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 50,000 · Sale (S): 19,500 @ $10.82 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Sale (S): 61,273 @ $7.86 · Sale (S): 30,544 @ $8.05 | EDGAR |
| 2025-02-10 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 233,333 · Option exercise (M): 233,333 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 7,693 @ $0 | EDGAR |
| 2024-02-02 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2023-10-11 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 600,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 9,792 @ $0 | EDGAR |
| 2022-05-23 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 14,035 @ $0 | EDGAR |
| 2022-04-08 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 17,845 @ $0 | EDGAR |
| 2021-11-24 | 4 | Adamas Pharmaceuticals Inc (ADMS) | Grant/award (A): 75,000 @ $0 · Code (U): 600,000 · Disposition to issuer (D): 250,000 (derivative) · Disposition to issuer (D): 200,000 (derivative) | EDGAR |
| 2021-03-03 | 4 | Adamas Pharmaceuticals Inc (ADMS) | Grant/award (A): 300,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-03 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1681098 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs